García-Villalón A L, Fernández N, Monge L, García J L, Gómez B, Diéguez G
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma, Madrid, España.
J Vasc Res. 1995 Nov-Dec;32(6):387-97. doi: 10.1159/000159114.
The main objective of this work was to study the role of potassium channels in the cholinergic relaxation of cutaneous arteries during cooling. Acetylcholine (10(-8)-10(-4) M) produced isometric concentration-dependent relaxation of precontracted segments of rabbit ear (cutaneous) and femoral (noncutaneous) arteries; this relaxation was higher at 24 degrees C (cooling) than at 37 degrees C in ear, but not in femoral, arteries. In both types of arteries, at 37 and 24 degrees C, the relaxation to acetylcholine was partially reduced by the inhibitor of nitric oxide synthase NG-nitro-L-arginine methyl ester (L-NAME, 10(-4) M), and the relaxation that remained after L-NAME was higher at 24 degrees C than at 37 degrees C in ear, but not in femoral, arteries. At 37 and 24 degrees C, the persistent relaxation to acetylcholine after L-NAME was further reduced by smooth muscle depolarization with medium containing a high concentration of potassium (6 x 10(-2) M), and with the nonspecific inhibitors of potassium channels tetraethylammonium (10(-2) M) or 4-aminopyridine (5 x 10(-3) M) in both ear and femoral arteries. In ear arteries, the inhibitor of high conductance calcium-activated potassium channels charybdotoxin (10(-7) M), alone or combined with L-NAME, reduced the relaxation to acetylcholine at 24 degrees C, but not at 37 degrees C. In femoral arteries, charybdotoxin alone did not modify, but combined with L-NAME reduced, the relaxation to acetylcholine at either temperature. At 37 and 24 degrees C, the inhibitor of low conductance calcium-activated potassium channels apamin (10(-7) M), the inhibitor of ATP-dependent potassium channels glibenclamide (10(-5) M) and the cyclooxygenase inhibitor meclofenamate (10(-5) M), alone or combined with L-NAME, did not modify the relaxation of both ear and femoral arteries to acetylcholine. These results suggest: (1) the cholinergic relaxation of cutaneous (ear) and noncutaneous (femoral) arteries could be mediated by endothelial nitric oxide and by activation of potassium channels, and (2) cooling increases the relaxation of cutaneous arteries to cholinergic stimulation, which may be mediated, in part, by an increased response of potassium channels.
这项工作的主要目的是研究钾通道在降温过程中对皮肤动脉胆碱能舒张的作用。乙酰胆碱(10⁻⁸ - 10⁻⁴ M)使预先收缩的兔耳(皮肤)和股(非皮肤)动脉段产生等长的浓度依赖性舒张;在兔耳动脉中,这种舒张在24℃(降温)时比在37℃时更强,但在股动脉中并非如此。在两种类型的动脉中,在37℃和24℃时,一氧化氮合酶抑制剂NG - 硝基 - L - 精氨酸甲酯(L - NAME,10⁻⁴ M)可部分降低对乙酰胆碱的舒张反应,且在兔耳动脉中,L - NAME处理后剩余的舒张反应在24℃时比在37℃时更强,但在股动脉中并非如此。在37℃和24℃时,用含高浓度钾(6×10⁻² M)的培养基使平滑肌去极化,以及使用钾通道非特异性抑制剂四乙铵(10⁻² M)或4 - 氨基吡啶(5×10⁻³ M),均可进一步降低L - NAME处理后兔耳和股动脉对乙酰胆碱的持续舒张反应。在兔耳动脉中,高电导钙激活钾通道抑制剂蝎毒素(10⁻⁷ M)单独或与L - NAME联合使用,可降低24℃时对乙酰胆碱的舒张反应,但在37℃时无此作用。在股动脉中,蝎毒素单独使用时不改变对乙酰胆碱的舒张反应,但与L - NAME联合使用时,在任一温度下均可降低对乙酰胆碱的舒张反应。在37℃和24℃时,低电导钙激活钾通道抑制剂蜂毒明肽(10⁻⁷ M)、ATP依赖性钾通道抑制剂格列本脲(10⁻⁵ M)以及环氧化酶抑制剂甲氯芬那酸(10⁻⁵ M)单独或与L - NAME联合使用,均不改变兔耳和股动脉对乙酰胆碱的舒张反应。这些结果表明:(1)皮肤(兔耳)和非皮肤(股)动脉的胆碱能舒张可能由内皮一氧化氮和钾通道的激活介导;(2)降温增加了皮肤动脉对胆碱能刺激的舒张反应,这可能部分由钾通道反应性增加介导。